CARsgen and Dispatch Bio Unite to Explore Innovative Cancer Treatments CARsgen and Dispatch Bio announced a groundbreaking clinical collaboration to evaluate the Flare platform and zevor-cel in solid tumors, set to begin in 2026 in China.

CARsgen and Dispatch Bio Unite to Explore Innovative Cancer Treatments #China #Shanghai #CAR_T-cell_Therapy #Solid_Tumors #Dispatch_Bio